{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:41:22Z","timestamp":1778773282938,"version":"3.51.4"},"reference-count":14,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2021,5,31]]},"DOI":"10.7883\/yoken.jjid.2020.589","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T22:06:40Z","timestamp":1604009200000},"page":"240-244","source":"Crossref","is-referenced-by-count":1,"title":["Does Quinolone- or Macrolide-Resistant &lt;i&gt;Streptococcus agalactiae&lt;\/i&gt; Bacteremia Affect Patient Outcome? A Multicenter Cohort Study"],"prefix":"10.7883","volume":"74","author":[{"given":"Satoru","family":"Mitsuboshi","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Kaetsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Date","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shinrakuen Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Tsuruma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sado General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Yamaga","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sado General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nagaoka Chuo General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kijima","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kido Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Nakashita","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Niigata City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Agano City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Tsugita","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Raabe VN, Shane AL. Group B <i>Streptococcus<\/i> (<i>Streptococcus agalactiae<\/i>). Microbiol Spectr. 2019;7:10.1128\/microbiolspec. GPP3-0007-2018.","DOI":"10.1128\/microbiolspec"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure, and antimicrobial resistance of group B <i>Streptococcus<\/i> strains recovered from colonized pregnant women. J Clin Microbiol. 2017;55:412-22.","DOI":"10.1128\/JCM.01615-16"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gajic I, Plainvert C, Kekic D, et al. Molecular epidemiology of invasive and non-invasive group B <i>Streptococcus<\/i> circulating in Serbia. Int J Med Microbiol. 2019;309:19-25.","DOI":"10.1016\/j.ijmm.2018.10.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bergal A, Loucif L, Benouareth DE, et al. Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of <i>Streptococcus agalactiae<\/i> clinical isolates from Guelma, Algeria and Marseille, France. Eur J Clin Microbiol Infect Dis. 2015;34:2339-48.","DOI":"10.1007\/s10096-015-2487-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wu C-J, Lai J-F, Huang I-W, et al. Multiclonal emergence of levofloxacin-resistant group B <i>Streptococcus<\/i>, Taiwan. J Antimicrob Chemother. 2017;72:3263-71.","DOI":"10.1093\/jac\/dkx297"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tsutsui A, Yahara K, Shibayama K. Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. J Infect Chemother. 2018;24:414-21.","DOI":"10.1016\/j.jiac.2018.01.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fujiya Y, Hayakawa K, Gu Y, et al. Age-related differences in clinical characteristics of invasive group G streptococcal infection: comparison with group A and group B streptococcal infections. PLoS One. 2019;14:e0211786.","DOI":"10.1371\/journal.pone.0211786"},{"key":"8","unstructured":"8. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 27th ed. Informational supplement. Document M100-S27. Wayne, PA: CLSI; 2017."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Neuman MI, Kelley M, Harper MB, et al. Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia. J Emerg Med. 2007;32:349-57.","DOI":"10.1016\/j.jemermed.2006.08.014"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cilloniz C, Albert RK, Liapikou A, et al. The effect of macrolide resistance on the presentation and outcome of patients hospitalized for <i>Streptococcus pneumoniae<\/i> pneumonia. Am J Respir Crit Care Med. 2015;191:1265-72.","DOI":"10.1164\/rccm.201502-0212OC"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kang CI, Song JH, Kim SH, et al. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection. 2013;41:151-7.","DOI":"10.1007\/s15010-012-0299-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Morozumi M, Wajima T, Takata M, et al. Molecular characteristics of group B streptococci isolated from adults with invasive infections in Japan. J Clin Microbiol. 2016;54:2695-2700.","DOI":"10.1128\/JCM.01183-16"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Back EE, O\u2019Grady EJ, Back JD. High rates of perinatal group B <i>Streptococcus<\/i> clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother. 2012;56:739-42.","DOI":"10.1128\/AAC.05794-11"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Simoni S, Vincenzi C, Brenciani A, et al. Molecular characterization of Italian isolates of fluoroquinolone-resistant <i>Streptococcus agalactiae<\/i> and relationships with chloramphenicol resistance. Microb Drug Resist. 2018;24:225-31.","DOI":"10.1089\/mdr.2017.0139"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/3\/74_JJID.2020.589\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T05:40:30Z","timestamp":1623303630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/3\/74_JJID.2020.589\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2020.589","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]}}}